NCT06610669

Brief Summary

The PMMHRI-Lp(a)-Registry is a non-interventional, single-center registry conducted in the Polish Mother's Memorial Hospital Research Institute (PMMHRI). The PMMHRI-Lp(a)-Registry was established in January 2022. Since then, all consecutive patients of the Department of Cardiology and Adult Congenital Heart Diseases, Department of Endocrinology, and outpatient cardiology and endocrinology clinics with the measured Lp(a) concentration have been included.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
25mo left

Started Jan 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress68%
Jan 2022Jun 2028

Study Start

First participant enrolled

January 1, 2022

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

September 20, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 24, 2024

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2028

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2028

Last Updated

September 24, 2024

Status Verified

August 1, 2024

Enrollment Period

6 years

First QC Date

September 20, 2024

Last Update Submit

September 23, 2024

Conditions

Lipoprotein(a), Hyper-Lp(a)-Emia

Keywords

lipoprotein(a)

Outcome Measures

Primary Outcomes (1)

  • Prevalence of hyper-Lp(a)-aemia among the Polish population, along with the identification of associated patient characteristics and risk factors

    5 years

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All consecutive patients of the Department of Cardiology and Adult Congenital Heart Diseases, Department of Endocrinology, and outpatient cardiology and endocrinology clinics with the measured Lp(a) concentration.

You may qualify if:

  • measured lipoprotein(a) concentration

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Polish Mother Memorial Research Institute

Lodz, 93-338, Poland

RECRUITING

Central Study Contacts

Maciej Banach, MD,PhD,FNLA,FAHA,FESC,FASA

CONTACT

+48 42 2711599maciej.banach@icloud.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 20, 2024

First Posted

September 24, 2024

Study Start

January 1, 2022

Primary Completion (Estimated)

January 1, 2028

Study Completion (Estimated)

June 1, 2028

Last Updated

September 24, 2024

Record last verified: 2024-08

Locations

PL(1)